ZNF861P

Across TCGA pan-cancer cohorts, ZNF861P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated ZNF861P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher ZNF861P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF861P expression acts as an unfavorable survival marker, although some lineages such as LAML and LIHC show a favorable association.

THCA, TGCT, and READ are the cancer types where ZNF861P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.214	0.938	<.001	99	view →
TGCT	DFS	Tertile	II,III,IV	0.363	0.954	<.001	72	view →
READ	OS	Tertile	III,IV	0.234	0.805	<.001	60	view →
KICH	OS	Tertile	All	0.191	0.875	.001	57	view →
LAML	DFS	Median	All	0.501	0.217	<.001	54	view →
THYM	OS	Tertile	All	0.836	0.980	.005	48	view →
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	21	view →
ACC	OS	Tertile	All	0.539	0.904	.003	21	view →
PCPG	DFS	Tertile	All	0.070	0.936	<.001	18	view →
LIHC	OS	Tertile	II,III,IV	0.706	0.399	.024	18	view →
ESCA	DFS	Quartile	II,III,IV	0.405	0.563	.027	16	view →
LGG	DFS	Tertile	All	0.656	0.386	.010	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

ZNF861P–THCA (OS)

Open the THCA breakdown →